Natural Killer cells (NK) are large granular lymphocytes of bone marrow origin that exhibit non-MHC restricted cytolytic activity against a variety of tumor and virally infected cells. The molecular basics of NK cell target recognition is relatively unknown. A receptor present on all NK cells and T cells that exhibit non-MHC restricted cytotoxicity has been identified and the gene for this receptor has been cloned. Previous work in our laboratory has shown that this receptor, 2B4, is able to activate cytolytic activity and cytokine secretion when conjugated by monoclonal antibody. However, it was recently shown that the gene for this receptor encodes two isoforms by an alternative splicing mechanism that differ solely in their cytoplasmic domains. These isoforms were shown to possess opposing functions in that one form functions as a stimulatory receptor and the other is inhibitory. Recently, the ligand for 2B4 has been identified as the CD48 molecule, which was previously thought to be the ligand for CD2. CD48 is expressed on all lymphoid cells and acts as a co- stimulatory molecule for B cells and Dendritic cells. However, the role of 2B4-CD48 interactions in the function of NK, T, B and dendritic cells as yet to be determined. In this proposal, we plan to characterize at a molecular level the signal transduction pathways involved in the function of both isoforms of the 2B4 receptor. We also plan to determine the ability of this receptor to communicate with other T or NK cell receptor signaling pathways. These studies will allow us to define the pathways that the 2B4 isoforms utilize in cellular communications and allow us to make predictions regarding the potential role of 2B4:CD48 interactions on immunological processes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
2P01AI038938-05
Application #
6212449
Study Section
Special Emphasis Panel (ZAI1-MSQ-I (S5))
Project Start
1995-09-30
Project End
2003-08-31
Budget Start
Budget End
Support Year
5
Fiscal Year
1999
Total Cost
Indirect Cost
City
Dallas
State
TX
Country
United States
Zip Code
75390
Johansson, Maria H; Taylor, Mesha A; Jagodic, Maja et al. (2006) Mapping of quantitative trait loci determining NK cell-mediated resistance to MHC class I-deficient bone marrow grafts in perforin-deficient mice. J Immunol 177:7923-9
Gao, Ning; Dang, Tam; Dunnick, Wesley A et al. (2005) Receptors and counterreceptors involved in NK-B cell interactions. J Immunol 174:4113-9
Mooney, Jill M; Klem, Jennifer; Wulfing, Christoph et al. (2004) The murine NK receptor 2B4 (CD244) exhibits inhibitory function independent of signaling lymphocytic activation molecule-associated protein expression. J Immunol 173:3953-61
Yuan, Dorothy; Bibi, Rula; Dang, Tam (2004) The role of adjuvant on the regulatory effects of NK cells on B cell responses as revealed by a new model of NK cell deficiency. Int Immunol 16:707-16
Morris, Margaret A; Koulich, Elena; Liu, Jingxuan et al. (2002) Definition of additional functional ligands for Ly49I(B6) using FVBLy49I(B6) transgenic mice and B6 natural killer cell effectors. Transplantation 74:1449-54
Klem, Jennifer; Verrett, Pamela C; Kumar, Vinay et al. (2002) 2B4 is constitutively associated with linker for the activation of T cells in glycolipid-enriched microdomains: properties required for 2B4 lytic function. J Immunol 169:55-62
Taylor, Mesha Austin; Ward, Brant; Schatzle, John D et al. (2002) Perforin- and Fas-dependent mechanisms of natural killer cell-mediated rejection of incompatible bone marrow cell grafts. Eur J Immunol 32:793-9
Morris, Margaret A; Liu, Jingxuan; Arora, Veera et al. (2002) B6 strain Ly49I inhibitory gene expression on T cells in FVB.Ly49IB6 transgenic mice fails to prevent normal T cell functions. J Immunol 169:3661-6
Murphy, W J; Koh, C Y; Raziuddin, A et al. (2001) Immunobiology of natural killer cells and bone marrow transplantation: merging of basic and preclinical studies. Immunol Rev 181:279-89
Boles, K S; Stepp, S E; Bennett, M et al. (2001) 2B4 (CD244) and CS1: novel members of the CD2 subset of the immunoglobulin superfamily molecules expressed on natural killer cells and other leukocytes. Immunol Rev 181:234-49

Showing the most recent 10 out of 43 publications